1. Home
  2. CMPX vs AEVA Comparison

CMPX vs AEVA Comparison

Compare CMPX & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • AEVA
  • Stock Information
  • Founded
  • CMPX 2014
  • AEVA 2019
  • Country
  • CMPX United States
  • AEVA United States
  • Employees
  • CMPX N/A
  • AEVA N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • AEVA Auto Parts:O.E.M.
  • Sector
  • CMPX Health Care
  • AEVA Consumer Discretionary
  • Exchange
  • CMPX Nasdaq
  • AEVA Nasdaq
  • Market Cap
  • CMPX 217.4M
  • AEVA 177.0M
  • IPO Year
  • CMPX N/A
  • AEVA N/A
  • Fundamental
  • Price
  • CMPX $1.66
  • AEVA $3.20
  • Analyst Decision
  • CMPX Strong Buy
  • AEVA Buy
  • Analyst Count
  • CMPX 3
  • AEVA 5
  • Target Price
  • CMPX $7.67
  • AEVA $10.03
  • AVG Volume (30 Days)
  • CMPX 441.1K
  • AEVA 255.1K
  • Earning Date
  • CMPX 11-07-2024
  • AEVA 11-06-2024
  • Dividend Yield
  • CMPX N/A
  • AEVA N/A
  • EPS Growth
  • CMPX N/A
  • AEVA N/A
  • EPS
  • CMPX N/A
  • AEVA N/A
  • Revenue
  • CMPX $850,000.00
  • AEVA $6,540,000.00
  • Revenue This Year
  • CMPX N/A
  • AEVA $109.97
  • Revenue Next Year
  • CMPX $950.68
  • AEVA $136.96
  • P/E Ratio
  • CMPX N/A
  • AEVA N/A
  • Revenue Growth
  • CMPX N/A
  • AEVA 89.40
  • 52 Week Low
  • CMPX $0.77
  • AEVA $2.20
  • 52 Week High
  • CMPX $2.34
  • AEVA $7.25
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 61.61
  • AEVA 60.21
  • Support Level
  • CMPX $1.42
  • AEVA $2.85
  • Resistance Level
  • CMPX $1.79
  • AEVA $3.05
  • Average True Range (ATR)
  • CMPX 0.14
  • AEVA 0.22
  • MACD
  • CMPX 0.01
  • AEVA 0.06
  • Stochastic Oscillator
  • CMPX 54.30
  • AEVA 92.31

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.

Share on Social Networks: